TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Recruiting

Phase 1

Phase 2

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Sponsor:

University of Chicago

Code:

NCT05108870

Conditions

Human Papilloma Virus

HPV

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Head and Neck Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HB-201

HB-202

Carboplatin

Paclitaxel

Transoral Robotic Surgery

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of Chicago on 2024-09-19.